Eligibility status
Target of antibody
Characterization method
Source
- CDI109
- SDIX, LLC109
- Abcam83
- Cell Signaling44
- Thermo Fisher40
- Kevin White33
- Assay Biotech28
- Origene28
- Bioss27
- Millipore27
- Aviva25
- Everest Biotech25
- MBLI21
- Novus21
- Rockland16
- Covance13
- Vincenzo Pirrotta8
- Victor Corces6
- Robert Horvitz5
- Robert White5
- BD Biosciences4
- LSBio4
- Sarah Elgin4
- Zen Bioscience4
- Abnova3
- Andrew Dingwall3
- BioLegend3
- Laszlo Tora3
- Mattias Mannervik3
- Unknown Source3
- ABclonal2
- Arshad Desai2
- Claude Desplan2
- Emery Bresnick2
- Erika Bach2
- Florence Maschat2
- Harald Saumweber2
- James Kadonaga2
- Pacific Immunology2
- Proteintech2
- Rainer Renkawitz2
- Roberto Mantovani2
- Stephen Crews2
- Steven Henikoff2
- Tom Williams and Sean Carroll2
- Yang Shi2
- Anthony Schwacha1
- Arno Greenleaf1
- Axxora1
- Callaini Guiliano1
- Carl Wu1
- Cayman1
- David Anderson1
- Diagenode1
- Dmitry Fyodorov1
- Donna Arndt-Jovin1
- Epitomics1
- Eric Lai1
- Francesca Palladino1
- Giacomo Cavalli1
- Haruhiko Siomi1
- Huabing Li and Vincenzo Pirrotta1
- Hugo Bellen1
- James Engel1
- Jan Larsson1
- Jean-Antoine Lepseant1
- Jianhong Wu and Tao Shi Hsieh1
- John Reinitz1
- Julie Ahringer1
- Karen Schulze and Hugo Bellen1
- Ken Cadigan1
- Kenneth Irvine1
- Kirsten Hagstrom1
- Lake Placid Biologicals1
- Marek Bartkuhn1
- Max Reuter1
- Nuria Paricio1
- Pamela Geyer1
- Paul Schedl, Jason Blanton and Greg Shanowe1
- Paul Yaswen1
- Peggy Farnham1
- RAN1
- RD Systems1
- ReproCELL1
- Richard Mann1
- Scott Hawley1
- Stephen Bell1
- Stephen Smale1
- Tirtha Das and Ross Cagan1
- Ulrich Laemmli1
- Victor Lobanenkov1
- William Kelly1